Category: Elodie Bailly

Paris Transplant Group at the SFT congress 2019

12/2/2019

The members of the Paris Transplant Group are present at the SFT congress which will take place from December 3, 2019 in Bordeaux, France.

Many lectures by the Paris Transplant Group are planned to present the ongoing research to the French transplant community. The presentations will cover:

The latest results of clinical research, including the TRANSFORM study carried out with Novartis,
Research on transplant prognosis for improved patient follow-up, including the iBox algorithm.
Advances made in understanding the mechanisms at work in the event of rejection or unsuccessful transplantation.

This research covers kidney, lung and other transplantation.

Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study

9/21/2019

The first universal algorithm for predicting the risk of kidney transplant loss, named iBox, has been developed, validated and just made public by teams from Europe and the US.

The iBox is designed for clinicians to personalize and improve patient follow-up. The iBox could also accelerate the development of new immunosuppressive treatments by reducing the duration of clinical trials and defining a valid surrogate endpoint.

Chronic kidney disease affects 1 out of 10 people worldwide and is steadily increasing. When it reaches end-stage renal disease and endangers the lives of patients, dialysis or transplantation is required.

Paris Transplant Group at the SFT congress 2019

Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study

Paris Transplant Group

CATEGORIES

ALl

Archives

Research

Partnerships

Paris Transplant Group